2025-04-06 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis

**0) Numerical Overview:**

Colgate-Palmolive Co (CL) is a consumer goods company that manufactures and sells oral hygiene, personal care, and household products worldwide.

* **Cumulative Return (CL):** 40.67%
* **Cumulative Return (VOO):** 71.02%
* **Return Difference (CL vs VOO):** -30.3%
* **Relative Divergence:** 53.1% (This indicates CL's performance is at the 53.1st percentile relative to its historical performance against VOO, considering the range of maximum and minimum divergence.)


**1) Alpha and Beta Analysis:**

The provided data shows varying alpha and beta values over different periods.  Alpha represents the excess return relative to the market (VOO), and Beta measures the volatility relative to the market.  Generally, positive alpha indicates outperformance, while a beta above 1 signifies higher volatility.  The data reveals inconsistent performance relative to the market. While positive alphas are observed in some periods, indicating outperformance, other periods show negative alphas, suggesting underperformance.  The beta fluctuates, suggesting volatility relative to the market varies over time.  The market capitalization (Cap(B)) generally increases over time reflecting company growth.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 14.0% | 4.8% | -16.0% | 0.1 | 51.5 |
| 2016-2018  | -12.0% | 63.2% | -29.0% | 0.2 | 41.6 |
| 2017-2019  | 7.0% | 63.2% | -22.0% | -0.1 | 49.4 |
| 2018-2020  | 25.0% | 63.2% | -4.0% | 0.6 | 62.8 |
| 2019-2021  | 38.0% | 13.1% | -36.0% | 0.9 | 64.1 |
| 2020-2022  | 16.0% | 69.0% | -4.0% | 0.9 | 60.6 |
| 2021-2023  | 7.0% | 69.0% | -21.0% | 0.7 | 62.9 |
| 2022-2024  | 14.0% | 69.0% | -1.0% | 0.6 | 73.3 |
| 2023-2025  | 18.0% | 61.2% | 15.0% | 0.4 | 74.3 |


**2) Recent Price Movement:**

* **Closing Price:** $91.66
* **Previous Close:** $96.00
* **Change:** -$4.52 (a significant drop)
* **5-Day Moving Average:** $93.76
* **20-Day Moving Average:** $92.07
* **60-Day Moving Average:** $89.81

The stock price is currently below its 5-day and 20-day moving averages, indicating a short-term downtrend.  However, it's above the 60-day moving average, suggesting some longer-term support. The significant daily drop warrants further investigation into potential catalysts.


**3) Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4693 (High Risk)  This suggests increased market volatility.
* **RSI:** 52.89 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.15 (Positive, indicating potential bullish momentum)
* **Recent Relative Strength Change:** +18.7% (Short-term upward trend)
* **Expected Return:** -40.5% (This is a significant negative expected return. Further analysis is needed to understand the basis of this estimate.)  This large negative expected return should be investigated further and potentially discounted given the other metrics.

The significant price drop of -$4.52 indicates a substantial negative shift, possibly due to market factors or company-specific news.  The long-term (2+ years) expected return relative to the S&P 500 requires clarification regarding the underlying methodology and assumptions.


**4) Recent Earnings Analysis:**

The provided earnings data show relatively stable revenue around $5 billion, with slight fluctuations. EPS has been consistently around $0.8-$0.9. There is duplication of the Oct 2024 data point.

| Date       | EPS  | Revenue       |
|------------|------|---------------|
| 2024-10-25 | 0.9  | $5.03B        |
| 2024-07-26 | 0.89 | $5.06B        |
| 2024-04-26 | 0.83 | $5.07B        |
| 2023-10-27 | 0.86 | $4.92B        |
| 2024-10-25 | 0.86 | $4.92B        |


**5) Financial Information:**

Revenue has remained relatively consistent over the past year. Profit margins are high and consistently around 60%, indicating strong profitability.  Equity and ROE fluctuate considerably, requiring further investigation into the underlying accounting practices and potential reasons for this volatility.  High ROE values are particularly noteworthy and should be examined closely for sustainability.

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $4.95B | 60.30% |
| 2024-09-30 | $5.03B | 61.08% |
| 2024-06-30 | $5.06B | 60.62% |
| 2024-03-31 | $5.07B | 60.00% |
| 2023-12-31 | $4.95B | 59.60% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $0.21B | 348.58% |
| 2024-09-30 | $0.43B | 169.43% |
| 2024-06-30 | $0.12B | 594.31% |
| 2024-03-31 | $0.23B | 296.96% |
| 2023-12-31 | $0.61B | 117.90% |


**6) Overall Analysis:**

Colgate-Palmolive (CL) shows mixed performance. While revenue and profit margins remain strong and consistent, the stock's recent performance has lagged behind the S&P 500. The significant recent price drop necessitates further investigation.  The highly volatile ROE figures require careful scrutiny.  The high Market Risk Indicator also suggests caution.  Before making any investment decisions, additional research into the reasons for the recent price drop, the highly variable ROE, and the -40.5% expected return are crucial.  A deeper dive into the company's financials, competitive landscape, and any recent news is recommended.  The provided data alone does not support a conclusive buy/sell recommendation.
